News / Press Release

Displaying 1 to 10 of 87 Previous   1   2   3   4   5   Next 10

May 5, 2010

BioDiscovery and Exiqon Sign OEM Agreement to Provide Complete microRNA Analysis Solution
BioDiscovery, Inc. a leader in integrated software solutions for microarray-based research, and Exiqon A/S, a leader in microRNA analysis products and services, announced today an OEM Agreement incorporating BioDiscovery’s array analysis and visualization software with Exiqon’s arrays.

March 18, 2010

BioDiscovery Releases ImaGene 9.0 for Array Image Quantification and Visualization
BioDiscovery Inc., the leading developer of integrated software solutions for high-throughput technologies announced today the release of ImaGene 9.0 for microarray image analysis.

March 15, 2010

BioDiscovery Releases Nexus Expression version 2 for gene regulation analysis
BioDiscovery, Inc. the pioneering developer of integrated software solutions for microarray-based research, announced today the release of Nexus Expression version 2 for gene expression analysis.

February 22, 2010

BioDiscovery Releases a Unique New Global Repository for Genomic Variation Data
BioDiscovery, Inc. a leader in integrated software solutions for microarray-based research, announced today the release of Nexus DB a unique new repository for storing, querying, and sharing of genomic variation data from its popular Nexus Copy Number software.

February 10, 2010

BioDiscovery Releases Nexus Copy Number Version 5.0 for DNA Copy Number Analysis and Visualization
BioDiscovery, Inc. a leader in integrated software solutions for microarray-based research, announced today the release of version 5 of its popular Nexus Copy Number software, the leading platform independent and user friendly application for DNA copy number analysis of microarray derived data.

December 7, 2009

Cancer Centers Renew and Expand BioDiscovery’s Nexus Copy Number Software Licenses
BioDiscovery, Inc. a global leader in integrated software solutions for microarray-based research, announced today a number of license renewals and expansions of its Nexus Copy Number product at leading cancer research centers.

May 14, 2009

BioDiscovery Relocates Corporate Office
BioDiscovery, Inc. the pioneering developer of integrated software solutions for microarray-based research, has relocated its corporate office to a new location within El Segundo, CA.

April 1, 2009

BioDiscovery Releases Nexus Copy Number Version 4 for DNA Copy Number Analysis and Visualization
BioDiscovery, Inc. the pioneering developer of integrated software solutions for microarray-based research, announced today the release of Nexus Copy Number Version 4, a platform independent and efficient application for DNA copy number analysis of microarray derived data.

February 2, 2009

Fox Chase Cancer Center’s Keystone Program in Blood Cell Development and Cancer adopts Nexus Copy Number and Nexus Expression
BioDiscovery Inc., the leading developer of integrated software solutions for microarray-based research announced today that Fox Chase Cancer Center’s Keystone Program in Blood Cell Development and Cancer has acquired a site license for Nexus Copy Number and Nexus Expression, two companion tools designed specifically for scientists working on DNA copy number and RNA expression analysis from microarray data.

October 27, 2008

Johns Hopkins Medical Institute acquires BioDiscovery’s Nexus Expression software for analysis of gene regulation
BioDiscovery Inc., the leading developer of integrated software solutions for microarray-based research announced today that the Johns Hopkins Medical Institute has acquired a multi-seat license of Nexus Expression, a new intuitive and powerful tool for microarray gene expression analysis.

BioDiscovery Snapshot


Founded
July 1997

Mission
BioDiscovery develops, markets and sells advanced software solutions for the analysis of data from high-throughput microarray and next-generation sequencing technologies providing Biologists and Geneticists with sophisticated, yet highly usable tools to analyze and interpret their data and draw meaningful conclusions.

Financial Status
Privately held

Customers
Over 3000 in over 30 countries

Core Competency
DNA copy number analysis, Image Analysis, Pattern Recognition, Enterprise Data Management, Knowledge Management, Gene Expression Analysis, and Bioinformatics


Logistics